FDA Approved: CREON — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved AbbVie's supplemental application for CREON (pancrelipase), updating its labeling to reflect expanded indications for exocrine pancreatic insuf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatitis

Drugs mentioned

• Creon (pancrelipase)

Snippet

SUPPL AP for CREON (PANCRELIPASE)